Cardiac rhythm disease management includes implantable devices, leads
and accessories along with external devices to treat and manage
arrhythmic conditions. Some of the key devices that are specifically
designed for cardiac rhythm disease management (CRDM) include
products for either too slow heart rhythm or too fast heart rhythm.
These include pacemakers, leads, electrophysiology catheters,
implantable defibrillators, ablation products, and information
systems for patient management.
Request Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=24455
Future CRDM products will focus on complete cardiac disease
management comprising expansion of diagnostic and monitoring
capabilities to help physicians monitor cardiac diseases and provide
improved care, transformation of existing patient and device
management tools which include in-home monitoring, wireless systems,
and an in-office solutions; physician access to real-time patient
information for analysis of heart failure and for better disease
management, reduced healthcare costs, and reduced clinic visits; and
leading-edge clinical trials to aid identify and treat patients at a
risk for cardiac diseases.
Some of the products of cardiac rhythm disease management use
returned product analysis as well as multicenter clinical studies for
performance observance. The product performance of CRDM products
comprise device survival estimates, performance notes, and advisory
summaries pertaining to implantable generators, cardiac
resynchronization therapy devices, implantable cardioverter
defibrillators, implantable pacing and defibrillation needs.
The number of individuals suffering from heart related conditions
stands at an all-time high across the world. Cardiovascular diseases,
which account for major chunk of heart diseases, trigger almost 35%
of overall deaths globally every year. Some of the risk factors of
cardiovascular diseases are smoking, obesity, hypertension, diabetes,
and high cholesterol.
Many cardiac devices are developed to help control complexities in
heart patients. Some of these are irregular heartbeats, problems with
hearts electrical impulse system, slow rate of heart beats, etc.
Cardiac rhythm disease management market is the established segment
of cardiovascular devices market. These devices are primarily used in
the treatment of patients suffering from symptoms of heart failure,
atrial fibrillation (AF), bradycardia, and people suffering from
irregular heartbeats, i.e. arrhythmias. Approximately, 35% of the
total deaths worldwide are triggered by cardiovascular diseases,
which accounts for major part of heart diseases. The high risk
factors of the cardiovascular diseases are diabetes, smoking,
hypertension, obesity, and high cholesterol levels. Other factors
which also relate and vary to the above mentioned factors are sex
ratio, ethnicity, and geography. For instance, a leading cause of
heart disease is ischemic heart disease. According to a 2014 WHO
report, ischemic heart disease accounts for 46% cardiovascular deaths
in men and 38% in women.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=24455
The global cardiac rhythm disease management market is expanding
rapidly. This market is driven by key factors such as rise in
cardiovascular and related diseases such as diabetes, change in
lifestyle, eating and drink habits, and rise in geriatric population.
Other important factors driving the expansion of this market are
technological advancements in cardiac devices, higher disposable
income, and increase in awareness amongst population about cardiac
diseases. However, lack of awareness about new technological
developments, lack of skilled expertise, high cost overall treatment
and devices are some factors restraining the growth of this market.
Global cardiac rhythm disease management market can be classified on
the basis of devices, disease indication, and end-users. In terms of
devices, the global cardiovascular rhythm disease management market
can be segmented into cardiac rhythm pacemakers, cardiac
resynchronization therapy, implantable cardioverter defibrillators,
and implantable loop recorder. Cardiac rhythm pacemakers can be
further sub-segmented into single chamber pacemakers and dual chamber
pacemakers. Cardiac resynchronization therapy can be further
sub-segmented into cardiac resynchronization therapy pacemakers and
cardiac resynchronization therapy defibrillators.
Implantable cardioverter defibrillators can be again sub-segmented
into transvenous implantable cardioverter defibrillators (T-ICDs) and
subcutaneous implantable cardioverter defibrillators (S-ICDs). In
terms of disease indication, the cardiac rhythm disease management
market can be segmented into arrhythmias, symptoms of heart failure,
bradycardia, and others. In terms of end-users, the market can be
segmented into hospitals, ambulatory and surgical centers, diagnostic
centers, homecare settings, and others.
In terms of geography, the global cardiac rhythm disease management
market can be segmented into North America, Europe, Asia Pacific,
Latin America, and Middle East & Africa. North America holds
major share due to technological advancements & maturity of the
market. It is projected in journal Scientific America in 2016, 1.7
million new cardiovascular disease cases were detected in the U.S and
the number of cases are anticipated to increase rapidly. The cardiac
rhythm disease management market in the region is also anticipated to
increase due to high expenditure in the health care sector.
Furthermore, the market in Europe is anticipated to expand due to
rising cases of heart and related disease, and rise in geriatric
population. The Asia Pacific cardiac rhythm disease management market
is projected to expand rapidly in the near future. Factors driving
the expansion of this market include rise in per capita income,
technological advancements, and increase in investments in healthcare
infrastructure. Manufacturers in the industry are eyeing an
opportunity in developing countries such as China and India.
Report Overview @
https://www.transparencymarketresearch.com/cardiac-rhythm-disease-management-market.html
Key players operating in the cardiac rhythm disease management market
include Medtronic, Boston Scientific Corporation, Biotronik, St. Jude
Medical, Inc., Abbott Laboratories, and Sorin Group.
About Us
Transparency Market Research is a next-generation market intelligence
provider, offering fact-based solutions to business leaders,
consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow,
evolve, and mature. Our real-time data collection methods along with
ability to track more than one million high growth niche products are
aligned with your aims. The detailed and proprietary statistical
models used by our analysts offer insights for making right decision
in the shortest span of time. For organizations that require specific
but comprehensive information we offer customized solutions through
adhoc reports. These requests are delivered with the perfect
combination of right sense of fact-oriented problem solving
methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems
with right methodology of research is the key to help enterprises
reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment